The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Humanigen Inc(NASDAQ:HGEN) 
Humanigen, Inc. is developing its portfolio of Humaneered® monoclonal antibodies to address cutting-edge CAR-T optimization and oncology treatments advancing safer, better, and more effective cancer therapies. Derived from the company's Humaneered® platform, lenzilumab and ifabotuzumab are monoclona...
Website: https://www.humanigen.com/
Founded: 2000
CEO: Cameron Durrant
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Share this website to your friends
Humanigen Op Cashflow Per Share ttm
Humanigen Free Cashflow Per Share ttm
Humanigen Cash Per Share ttm
Humanigen P/S ratio ttm
Humanigen (GAAP) P/E ratio ttm
Humanigen P/B ratio ttm
No extra charts and metrics for this ticker.